(Q47426603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

human subject research project

25 December 2019

main subject

obesity

0 references

0 references

author

Jens Juul Holst

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Per M. Hellstrom

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Erik Näslund

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

N King

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Mansten

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

N Adner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Gutniak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Nutrition

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

439-446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

The central neural connections of the area postrema of the rat.

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20031064

21 January 2018

Identifiers

DOI

10.1079/BJN20031064

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15005830%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference